Area of research
Molecular Biology · Hardware and Architecture
Research interest
Research focused on Glioma and In vivo, with related work in Docetaxel, Internalization, Endocytosis. Notable publications include 'Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization', 'Angiopep-2 and Activatable Cell-Penetrating Peptide Dual-Functionalized Nanoparticles for Systemic Glioma-Targeting Delivery', and 'Whole-cell SELEX aptamer-functionalised poly(ethyleneglycol)-poly(ε-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy'.
Angiopep-2 and Activatable Cell-Penetrating Peptide Dual-Functionalized Nanoparticles for Systemic Glioma-Targeting Delivery
RGD and Interleukin-13 Peptide Functionalized Nanoparticles for Enhanced Glioblastoma Cells and Neovasculature Dual Targeting Delivery and Elevated Tumor Penetration
Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization
Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment
Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth
Incorporation of Lapatinib Into Lipoprotein-Like Nanoparticles with Enhanced Water Solubility and Anti-Tumor Effect in Breast Cancer
Whole-cell SELEX aptamer-functionalised poly(ethyleneglycol)-poly(ε-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy
Anti-glioma effect and safety of docetaxel-loaded nanoemulsion